Snapshot
The global Friedreich Ataxia Drug market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Friedreich Ataxia Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Adverum Biotechnologies Inc
BioMarin Pharmaceutical Inc.
Biovista Inc.
Cardero Therapeutics Inc
Catabasis Pharmaceuticals, Inc.
Forward Pharma A/S
Ixchel Pharma LLC
Pfizer Inc
ProQR Therapeutics NV
RaNA Therapeutics Inc
Reata Pharmaceuticals Inc
Retrotope Inc
Shire Plc
STATegics Inc
Voyager Therapeutics Inc
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Clinic
Hospital
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Friedreich Ataxia Drug Industry
Figure Friedreich Ataxia Drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Friedreich Ataxia Drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Friedreich Ataxia Drug
1.2.2 Downstream
Table Application Segment of Friedreich Ataxia Drug
Table Global Friedreich Ataxia Drug Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Friedreich Ataxia Drug Market by Type
3.1 By Type
3.1.1 ADVM-063
Table Major Company List of ADVM-063
3.1.2 AGIL-FA
Table Major Company List of AGIL-FA
3.1.3 BHV-4157
Table Major Company List of BHV-4157
3.1.4 BVA-202
Table Major Company List of BVA-202
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Friedreich Ataxia Drug Market 2016-2020, by Type, in USD Million
Figure Global Friedreich Ataxia Drug Market Growth 2016-2020, by Type, in USD Million
Table Global Friedreich Ataxia Drug Market 2016-2020, by Type, in Volume
Figure Global Friedreich Ataxia Drug Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Friedreich Ataxia Drug Market Forecast 2021-2026, by Type, in USD Million
Table Global Friedreich Ataxia Drug Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Adverum Biotechnologies Inc (Company Profile, Sales Data etc.)
4.1.1 Adverum Biotechnologies Inc Profile
Table Adverum Biotechnologies Inc Overview List
4.1.2 Adverum Biotechnologies Inc Products & Services
4.1.3 Adverum Biotechnologies Inc Business Operation Conditions
Table Business Operation of Adverum Biotechnologies Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 BioMarin Pharmaceutical Inc. (Company Profile, Sales Data etc.)
4.2.1 BioMarin Pharmaceutical Inc. Profile
Table BioMarin Pharmaceutical Inc. Overview List
4.2.2 BioMarin Pharmaceutical Inc. Products & Services
4.2.3 BioMarin Pharmaceutical Inc. Business Operation Conditions
Table Business Operation of BioMarin Pharmaceutical Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Biovista Inc. (Company Profile, Sales Data etc.)
4.3.1 Biovista Inc. Profile
Table Biovista Inc. Overview List
4.3.2 Biovista Inc. Products & Services
4.3.3 Biovista Inc. Business Operation Conditions
Table Business Operation of Biovista Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Cardero Therapeutics Inc (Company Profile, Sales Data etc.)
4.4.1 Cardero Therapeutics Inc Profile
Table Cardero Therapeutics Inc Overview List
4.4.2 Cardero Therapeutics Inc Products & Services
4.4.3 Cardero Therapeutics Inc Business Operation Conditions
Table Business Operation of Cardero Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Catabasis Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.5.1 Catabasis Pharmaceuticals, Inc. Profile
Table Catabasis Pharmaceuticals, Inc. Overview List
4.5.2 Catabasis Pharmaceuticals, Inc. Products & Services
4.5.3 Catabasis Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Catabasis Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Forward Pharma A/S (Company Profile, Sales Data etc.)
4.6.1 Forward Pharma A/S Profile
Table Forward Pharma A/S Overview List
4.6.2 Forward Pharma A/S Products & Services
4.6.3 Forward Pharma A/S Business Operation Conditions
Table Business Operation of Forward Pharma A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Ixchel Pharma LLC (Company Profile, Sales Data etc.)
4.7.1 Ixchel Pharma LLC Profile
Table Ixchel Pharma LLC Overview List
4.7.2 Ixchel Pharma LLC Products & Services
4.7.3 Ixchel Pharma LLC Business Operation Conditions
Table Business Operation of Ixchel Pharma LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Pfizer Inc (Company Profile, Sales Data etc.)
4.8.1 Pfizer Inc Profile
Table Pfizer Inc Overview List
4.8.2 Pfizer Inc Products & Services
4.8.3 Pfizer Inc Business Operation Conditions
Table Business Operation of Pfizer Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 ProQR Therapeutics NV (Company Profile, Sales Data etc.)
4.9.1 ProQR Therapeutics NV Profile
Table ProQR Therapeutics NV Overview List
4.9.2 ProQR Therapeutics NV Products & Services
4.9.3 ProQR Therapeutics NV Business Operation Conditions
Table Business Operation of ProQR Therapeutics NV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 RaNA Therapeutics Inc (Company Profile, Sales Data etc.)
4.10.1 RaNA Therapeutics Inc Profile
Table RaNA Therapeutics Inc Overview List
4.10.2 RaNA Therapeutics Inc Products & Services
4.10.3 RaNA Therapeutics Inc Business Operation Conditions
Table Business Operation of RaNA Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Reata Pharmaceuticals Inc (Company Profile, Sales Data etc.)
4.11.1 Reata Pharmaceuticals Inc Profile
Table Reata Pharmaceuticals Inc Overview List
4.11.2 Reata Pharmaceuticals Inc Products & Services
4.11.3 Reata Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Reata Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Retrotope Inc (Company Profile, Sales Data etc.)
4.12.1 Retrotope Inc Profile
Table Retrotope Inc Overview List
4.12.2 Retrotope Inc Products & Services
4.12.3 Retrotope Inc Business Operation Conditions
Table Business Operation of Retrotope Inc (Sales Revenue, Cost, Gross Margin)
4.13 Shire Plc (Company Profile, Sales Data etc.)
4.13.1 Shire Plc Profile
Table Shire Plc Overview List
4.13.2 Shire Plc Products & Services
4.13.3 Shire Plc Business Operation Conditions
Table Business Operation of Shire Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 STATegics Inc (Company Profile, Sales Data etc.)
4.14.1 STATegics Inc Profile
Table STATegics Inc Overview List
4.14.2 STATegics Inc Products & Services
4.14.3 STATegics Inc Business Operation Conditions
Table Business Operation of STATegics Inc (Sales Revenue, Cost, Gross Margin)
4.15 Voyager Therapeutics Inc (Company Profile, Sales Data etc.)
4.15.1 Voyager Therapeutics Inc Profile
Table Voyager Therapeutics Inc Overview List
4.15.2 Voyager Therapeutics Inc Products & Services
4.15.3 Voyager Therapeutics Inc Business Operation Conditions
Table Business Operation of Voyager Therapeutics Inc (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Friedreich Ataxia Drug Sales Revenue 2016-2020, by Company, in USD Million
Table Global Friedreich Ataxia Drug Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Friedreich Ataxia Drug Sales Revenue Share in 2020, by Company, in USD Million
Table Global Friedreich Ataxia Drug Sales Volume 2016-2020, by Company, in Volume
Table Global Friedreich Ataxia Drug Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Friedreich Ataxia Drug Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Friedreich Ataxia Drug Market Concentration, in 2020
Figure Europe Friedreich Ataxia Drug Market Market Concentration, in 2020
Figure Asia-Pacific Friedreich Ataxia Drug MMarket Concentration, in 2020
Figure South America Friedreich Ataxia Drug Market Concentration, in 2020
Figure Middle East & Africa Friedreich Ataxia Drug Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Clinic
Figure Friedreich Ataxia Drug Demand in Clinic, 2016-2020, in USD Million
Figure Friedreich Ataxia Drug Demand in Clinic, 2016-2020, in Volume
6.1.2 Demand in Hospital
Figure Friedreich Ataxia Drug Demand in Hospital, 2016-2020, in USD Million
Figure Friedreich Ataxia Drug Demand in Hospital, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Friedreich Ataxia Drug Demand in Others, 2016-2020, in USD Million
Figure Friedreich Ataxia Drug Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Friedreich Ataxia Drug Demand Forecast 2021-2026, by Application, in USD Million
Figure Friedreich Ataxia Drug Market Growth 2021-2026, by Application, in USD Million
Figure Friedreich Ataxia Drug Market Share in 2026, by Application, in USD Million
Table Friedreich Ataxia Drug Demand Forecast 2021-2026, by Application, in Volume
Table Friedreich Ataxia Drug Market Growth 2021-2026, by Application, in Volume
Table Friedreich Ataxia Drug Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Friedreich Ataxia Drug Production 2016-2020, by Region, in USD Million
Table Friedreich Ataxia Drug Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Friedreich Ataxia Drug Market 2016-2020, by Region, in USD Million
Table Global Friedreich Ataxia Drug Market Share 2016-2020, by Region, in USD Million
Table Global Friedreich Ataxia Drug Market 2016-2020, by Region, in Volume
Table Global Friedreich Ataxia Drug Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Friedreich Ataxia Drug Market Size and Growth 2016-2020, in USD Million
Figure North America Friedreich Ataxia Drug Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Friedreich Ataxia Drug Market Size 2016-2020, by Country, in USD Million
Table North America Friedreich Ataxia Drug Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Friedreich Ataxia Drug Market Size and Growth 2016-2020, in USD Million
Figure Europe Friedreich Ataxia Drug Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Friedreich Ataxia Drug Market Size 2016-2020, by Country, in USD Million
Table Europe Friedreich Ataxia Drug Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Friedreich Ataxia Drug Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Friedreich Ataxia Drug Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Friedreich Ataxia Drug Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Friedreich Ataxia Drug Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Friedreich Ataxia Drug Market Size and Growth 2016-2020, in USD Million
Figure South America Friedreich Ataxia Drug Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Friedreich Ataxia Drug Market Size 2016-2020, by Country, in USD Million
Table South America Friedreich Ataxia Drug Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Friedreich Ataxia Drug Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Friedreich Ataxia Drug Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Friedreich Ataxia Drug Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Friedreich Ataxia Drug Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Friedreich Ataxia Drug Market Forecast 2021-2026, by Region, in USD Million
Table Friedreich Ataxia Drug Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
1. Table Upstream Segment of Friedreich Ataxia Drug
2. Table Application Segment of Friedreich Ataxia Drug
3. Table Global Friedreich Ataxia Drug Market 2016-2026, by Application, in USD Million
4. Table Major Company List of AGIL-FA
5. Table Major Company List of BHV-4157
6. Table Major Company List of BVA-202
7. Table Major Company List of Others
8. Table Global Friedreich Ataxia Drug Market 2016-2020, by Type, in USD Million
9. Table Global Friedreich Ataxia Drug Market 2016-2020, by Type, in Volume
10. Table Global Friedreich Ataxia Drug Market Forecast 2021-2026, by Type, in USD Million
11. Table Global Friedreich Ataxia Drug Market Forecast 2021-2026, by Type, in Volume
12. Table Adverum Biotechnologies Inc Overview List
13. Table Business Operation of Adverum Biotechnologies Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table BioMarin Pharmaceutical Inc. Overview List
15. Table Business Operation of BioMarin Pharmaceutical Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Biovista Inc. Overview List
17. Table Business Operation of Biovista Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Cardero Therapeutics Inc Overview List
19. Table Business Operation of Cardero Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Catabasis Pharmaceuticals, Inc. Overview List
21. Table Business Operation of Catabasis Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Forward Pharma A/S Overview List
23. Table Business Operation of Forward Pharma A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Ixchel Pharma LLC Overview List
25. Table Business Operation of Ixchel Pharma LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Pfizer Inc Overview List
27. Table Business Operation of Pfizer Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table ProQR Therapeutics NV Overview List
29. Table Business Operation of ProQR Therapeutics NV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table RaNA Therapeutics Inc Overview List
31. Table Business Operation of RaNA Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table Reata Pharmaceuticals Inc Overview List
33. Table Business Operation of Reata Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
34. Table Retrotope Inc Overview List
35. Table Business Operation of Retrotope Inc (Sales Revenue, Cost, Gross Margin)
36. Table Shire Plc Overview List
37. Table Business Operation of Shire Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
38. Table STATegics Inc Overview List
39. Table Business Operation of STATegics Inc (Sales Revenue, Cost, Gross Margin)
40. Table Voyager Therapeutics Inc Overview List
41. Table Business Operation of Voyager Therapeutics Inc (Sales Revenue, Cost, Gross Margin)
42. Table Global Friedreich Ataxia Drug Sales Revenue 2016-2020, by Company, in USD Million
43. Table Global Friedreich Ataxia Drug Sales Revenue Share 2016-2020, by Company, in USD Million
44. Table Global Friedreich Ataxia Drug Sales Volume 2016-2020, by Company, in Volume
45. Table Global Friedreich Ataxia Drug Sales Volume Share 2016-2020, by Company, in Volume
46. Table Regional Demand Comparison List
47. Table Major Application in Different Regions
48. Table Friedreich Ataxia Drug Demand Forecast 2021-2026, by Application, in USD Million
49. Table Friedreich Ataxia Drug Demand Forecast 2021-2026, by Application, in Volume
50. Table Friedreich Ataxia Drug Market Growth 2021-2026, by Application, in Volume
51. Table Friedreich Ataxia Drug Market Share in 2026, by Application, in Volume
52. Table Friedreich Ataxia Drug Production 2016-2020, by Region, in USD Million
53. Table Friedreich Ataxia Drug Production 2016-2020, by Region, in Volume
54. Table Global Friedreich Ataxia Drug Market 2016-2020, by Region, in USD Million
55. Table Global Friedreich Ataxia Drug Market Share 2016-2020, by Region, in USD Million
56. Table Global Friedreich Ataxia Drug Market 2016-2020, by Region, in Volume
57. Table Global Friedreich Ataxia Drug Market Share 2016-2020, by Region, in Volume
58. Table North America Friedreich Ataxia Drug Market Size 2016-2020, by Country, in USD Million
59. Table North America Friedreich Ataxia Drug Market Size 2016-2020, by Country, in Volume
60. Table Europe Friedreich Ataxia Drug Market Size 2016-2020, by Country, in USD Million
61. Table Europe Friedreich Ataxia Drug Market Size 2016-2020, by Country, in Volume
62. Table Asia-Pacific Friedreich Ataxia Drug Market Size 2016-2020, by Country, in USD Million
63. Table Asia-Pacific Friedreich Ataxia Drug Market Size 2016-2020, by Country, in Volume
64. Table South America Friedreich Ataxia Drug Market Size 2016-2020, by Country, in USD Million
65. Table South America Friedreich Ataxia Drug Market Size 2016-2020, by Country, in Volume
66. Table Middle East & Africa Friedreich Ataxia Drug Market Size 2016-2020, by Country, in USD Million
67. Table Middle East & Africa Friedreich Ataxia Drug Market Size 2016-2020, by Country, in Volume
68. Table Friedreich Ataxia Drug Market Forecast 2021-2026, by Region, in USD Million
69. Table Friedreich Ataxia Drug Market Forecast 2021-2026, by Region, in Volume
70. Table Price Factors List
List of Figure
1. Figure Friedreich Ataxia Drug Industry Chain Structure
2. Figure Global Friedreich Ataxia Drug Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Friedreich Ataxia Drug Market Growth 2016-2020, by Type, in Volume
4. Figure Global Friedreich Ataxia Drug Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Friedreich Ataxia Drug Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Friedreich Ataxia Drug Market Concentration, in 2020
7. Figure Europe Friedreich Ataxia Drug Market Market Concentration, in 2020
8. Figure Asia-Pacific Friedreich Ataxia Drug MMarket Concentration, in 2020
9. Figure South America Friedreich Ataxia Drug Market Concentration, in 2020
10. Figure Middle East & Africa Friedreich Ataxia Drug Market Concentration, in 2020
11. Figure Friedreich Ataxia Drug Demand in Clinic, 2016-2020, in USD Million
12. Figure Friedreich Ataxia Drug Demand in Clinic, 2016-2020, in Volume
13. Figure Friedreich Ataxia Drug Demand in Hospital, 2016-2020, in USD Million
14. Figure Friedreich Ataxia Drug Demand in Hospital, 2016-2020, in Volume
15. Figure Friedreich Ataxia Drug Demand in Others, 2016-2020, in USD Million
16. Figure Friedreich Ataxia Drug Demand in Others, 2016-2020, in Volume
17. Figure Friedreich Ataxia Drug Market Growth 2021-2026, by Application, in USD Million
18. Figure Friedreich Ataxia Drug Market Share in 2026, by Application, in USD Million
19. Figure North America Friedreich Ataxia Drug Market Size and Growth 2016-2020, in USD Million
20. Figure North America Friedreich Ataxia Drug Market Size and Growth 2016-2020, in Volume
21. Figure Europe Friedreich Ataxia Drug Market Size and Growth 2016-2020, in USD Million
22. Figure Europe Friedreich Ataxia Drug Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific Friedreich Ataxia Drug Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific Friedreich Ataxia Drug Market Size and Growth 2016-2020, in Volume
25. Figure South America Friedreich Ataxia Drug Market Size and Growth 2016-2020, in USD Million
26. Figure South America Friedreich Ataxia Drug Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa Friedreich Ataxia Drug Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa Friedreich Ataxia Drug Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview
Request Sample 
Request Discount 
Inquire Before Buy
